Navigation Links
PharmAthene Appoints Brian A. Markison to the Company's Board of Directors
Date:9/26/2011

ANNAPOLIS, Md., Sept. 26, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today announced the appointment of Brian A. Markison to the Company's Board of Directors, effective September 22, 2011.

Mr. Markison was recently appointed to the position of President and Chief Executive Officer for Nycomed U.S. which will be spun out from the acquisition of Nycomed A/S by Takeda Pharmaceuticals.   Prior to joining Nycomed, A/S, Mr. Markison served as Chairman, President and Chief Executive Officer of King Pharmaceuticals, where he successfully led the Company through a $3.6 billion acquisition by Pfizer.  Preceding his tenure at King, Mr. Markison held various executive leadership positions at Bristol-Myers Squibb, including, President of Oncology/  Virology and Oncology Therapeutics Network; Senior Vice President, Licensing & External Development and Mergers/Acquisitions; President, Neuroscience / Infectious Disease and Dermatology;  and Vice President, Northeast Sales Primary Care.

"It is with great pleasure that we welcome Brian to PharmAthene's Board of Directors," remarked Mitchel Sayare, Ph.D., Chairman of the Board of PharmAthene.  "With more than 30 years of distinguished service in the pharmaceutical industry in a variety of executive leadership roles, Brian's breadth of industry knowledge and experience will be an invaluable asset to PharmAthene as we chart the next phase of our Company's evolution towards commercial success."  

"I am delighted to join the Board of PharmAthene, particularly at this transformative time in the company's history," commented Mr. Markison.  "With potential revenues beginning as soon as 2012 based upon a 50/50 profit split of worldwide sales of SIGA Technologies' innovative smallpox
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
2. Department of Defense Awards $5.7 Million Contract to PharmAthene for Nerve Agent Medical Countermeasure Program
3. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
4. PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
5. PharmAthene Completes $6.5 Million Registered Direct Offering
6. PharmAthene Reports First Quarter 2011 Financial and Operating Results
7. PharmAthene to Host Year-End 2010 Earnings Conference Call and Webcast on Monday, March 28, 2011
8. PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
9. PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
10. PharmAthene Reports Third Quarter 2010 Financial and Operational Results
11. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... According to new market research ... Types (Colocation, Enterprise, Telecom), by Design Types (Electrical, ... 2, Tier 3, Tier 4) - Global Forecast ... the Data Center Construction Market into various segments ... This research report also identifies the factors driving ...
(Date:10/25/2014)... 2014 SonaCare Medical, LLC, leader ... technology, announced that its Board of Directors has ... Officer, President and member of the Board effective ... take-on expanded responsibilities within the company, including further ... overseeing commercialization, manufacturing and finance. , Dr. ...
(Date:10/25/2014)... Biopharmaceuticals, Inc. (OTCBB: RGRX) ("the Company" or "RegeneRx") today ... on Thymosins in Health and Disease in ... beta 4 (TB4) linked with rhodamine (a fluorescent tracer ... rodent model of stroke, it was visualized outside of ... tissue of the brain).   The leakage of TB4 in ...
(Date:10/22/2014)... -- Research and Markets has announced ... Market (Product types, Application, Technology, End User and ... Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... offering. This new report titled, ... and Geography) Global Size, Industry Analysis, Trends, Opportunities, ...
Breaking Biology Technology:Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 2Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 3Data Center Construction Market Worth $22.73 Billion by 2019 - New Report by MarketsandMarkets 4SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3
... recent report that probably went unnoticed outside the academic ... released figures that show why the rest of us ... for scientific research. The numbers demonstrate that investment in ... it's about creating jobs for the 21st century economy. ...
... Technical College would like to see more women going into ... women in IT careers has declined from a high of 41 ... And at MATC, enrollment of women in IT programs has dropped ... IT Expo at the college on Wednesday was Patricia Prime, ...
... . and Imaxio S.A. (Saint-Beauzire, France) have ... manufacture and sell OverExpress bacterial cells for ... retain the right to license the use of OverExpress ... cells to commercial licensees. No license will be required ...
Cached Biology Technology:Tapping hidden assets: Wisconsin researchers who can create jobs 2Tapping hidden assets: Wisconsin researchers who can create jobs 3Tapping hidden assets: Wisconsin researchers who can create jobs 4MATC seeks to turn around falling tech enrollment among women 2Lucigen Corp. enters global licensing agreement 2
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
(Date:10/15/2014)... linked increased resistance to bacterial pneumonia in female mice ... estrogen. , Females are naturally more resistant to respiratory ... has shown that increased resistance to bacterial pneumonia in ... synthase 3 (NOS3). They also show that this enzyme ... sex hormone estrogen. , The team, lead by Professor ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to ... the development of skin cancers by turning on an ... skin cells. , Previously considered protective, SIRT6 is part ... help regulate genomic stability and prevent some of the ... damage, which can lead to cancer. This study, in ...
Breaking Biology News(10 mins):Sandata Announces Case Study with Quality Care Services, Inc. 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
... Mass. Joshua Kritzer, assistant professor in the School ... University, has been awarded one of 33 NIH Director,s ... awarded by the National Institutes of Health. The ... to support unusually creative new investigators with highly innovative ...
... -- November 12, 2010 --Canadian biologist Chris Wood was ... Science. The Award was presented by Dr. Philip Campbell, ... for Graduate Studies annual meeting in Toronto earlier this ... Royal Society of Canada, is a professor in the ...
... Powdery mildew is a fungus that infects both crop and ... cause immense crop loss. Despite decades of intense research, little ... to invade the host,s epidermal cells. A European research group ... of Zurich, now published a study in Science ...
Cached Biology News:Tufts University chemist earns prestigious award for promising research on drug development 2Nature honors outstanding faculty mentor 2Fertility or powdery mildew resistance? 2Fertility or powdery mildew resistance? 3
Whole blood is collected from mice (Swiss Webster, 8-10 weeks old,either sex) and processed within 45 minutes of collection. The complement is then filtered and pooled on ice, bottled and stored at -...
... incorporating the sophisticated DirectDrive architecture and ... Varian NMR System is undeniably the ... Varian NMR System features parallel controllers ... providing pulse sequence programming power with ...
... Anti-HMGN2/HMG-17 Immunogen : Recombinant ... pH7.4, 5mg/ml BSA, 0.15M NaCl, ... addition of glycerol to 30% ... immunoblot on acid extracts of ...
Luminometers...
Biology Products: